Associations of adiponectin with paraoxonase 1 and sE-selectin in hemodialyzed patients

Kidney and Blood Pressure Research

Volumn 32, Issue 5, 2009, Pages 360-365

  Peti, Attila ^a   Csiky, Botond ^c   Guth, Eszter ^c   Kenyeres, Peter ^b   Varga, Zsuzsa ^d   Seres, Ildiko ^d   Jeney, Zoltan ^d   Juhasz, Maria ^d   Mezosi, Emese ^b   Paragh, Gyorgy ^d   Kovacs, Gabor L ^a,e   Bajnok, Laszlo ^b  

^a Institute of Laboratory Medicine   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c FMC Dialysis Center Pecs   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e MEDIPOLIS Knowledge Center   (Hungary)

Author keywords

Adiponectin; Hemodialysis; Insulin resistance; Serum paraoxonase 1; Soluble E selectin

Indexed keywords

ADIPONECTIN; ALBUMIN; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SOLUBLE E SELECTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTOR VARIABLE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; ARYLDIALKYLPHOSPHATASE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; E-SELECTIN; FEMALE; FIBRINOGEN; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 70350542690     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000254335     Document Type: Article

References (22)

1. Guebre-Egziabher F, Drai J, Fouque D: Adiponectin and chronic kidney disease. J Ren Nutr 2007; 17: 9-12.
2. Chudek J, Adamczak M, Karkoszka H, Budzinski G, Ignacy W, Funahashi T, Matsuzawa Y, Cierpka L, Kokot F, Wiecek A: Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003; 35: 2186-2189. (Pubitemid 37194359)
3. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D: Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20: 129-134.
4. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 2002; 13: 134-141.
5. Takemoto F, Katori H, Sawa N, Hoshino J, Suwabe T, Nakanishi S, Arai S, Fukuda S, Kodaka K, Shimada M, Yamazaki C, Yokoyama K, Nakano Y, Funahashi T, Ubara Y, Yamada A, Takaichi K, Uchida S: Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients: a Japanese prospective eight-year study. Nephron Clin Pract 2009; 111:c12-c20.
6. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599-2606. (Pubitemid 44300977)
7. Beige J, Heipmann K, Stumvoll M, Korner A, Kratzsch J: Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Expert Opin Ther Targets 2009; 13: 163-173.
8. Mackness M, Durrington P, Mackness B: Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Curr Opin Lipidol 2004; 15: 399-404.
9. Paragh G, Seres I, Balogh Z, Varga Z, Karpati I, Matyus J, Ujhelyi L, Kakuk G: The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 1998; 80: 166-170.
10. Schiavon R, Battaglia P, De Fanti E, Fasolin A, Biasioli S, Targa L, Guidi G: HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism. Clin Chim Acta 2002; 324: 39-44.
11. Dirican M, Akca R, Sarandol E, Dilek K: Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Nephron 2004; 17: 813-818.
12. Varga Z, Paragh G, Seres I, Kakuk G, Karpati I, Matyus J, Csongradi E, Karanyi Z, Balla J, Bajnok L, Juhasz A: Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients. Nephron Clin Pract 2006; 103: c114-c120.
13. Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G: Relationship of adiponectin to antioxidant enzyme paraoxonase 1. Atherosclerosis 2008; 197: 363-367.
14. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745-1751.
15. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB: Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 4542-4548.
16. Kantartzis K, Rittig K, Balletshofer B, Machann J, Schick F, Porubska K, Fritsche A, Haring HU, Stefan N: The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 2006; 52: 1934-1942.
17. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A: Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 1998; 79: 399-407.
18. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysed patients and subjects with normal renal function. Am J Kidney Dis 2004; 43: 1047-1055.
19. Diez JJ, Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R: Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005; 62: 242-249.
20. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L: Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004; 65: 274-281.
21. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB: The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs 2004; 27: 835-841.
22. Chen HY, Kao TW, Huang JW, Chu TS, Wu KD: Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 2008; 26: 138-144.